Deprescribing and Polypharmacy in an Aging Population
- 1st Edition - August 22, 2023
- Latest edition
- Author: Ali Elbeddini
- Language: English
Deprescribing and Polypharmacy in an Aging Population supports healthcare professionals across global healthcare institutions in reducing polypharmacy-related drug replated proble… Read more
Deprescribing and Polypharmacy in an Aging Population supports healthcare professionals across global healthcare institutions in reducing polypharmacy-related drug replated problems (DRPs) by working with patients, families, interprofessional healthcare professionals, and educational institutions to develop, implement, test, improve upon, and educate on strategies for deprescribing and optimizing patient safety. Polypharmacy, the use of multiple medications at the same time by one person, is very common in various patient populations, including those who lack primary physicians, patients with mental health conditions, patients with multiple chronic conditions, and in the aging population.
- Emphasizes the importance of involving a multidisciplinary team in deprescribing efforts
- Identifies barriers and enablers for the implementation of deprescribing programs
- Develops strategies to address barriers and optimize enablers for deprescribing implementation
Healthcare professionals involved in the circle of care and Pharmacy and medical school students & residents and professors, Hospital leadership and Policy makers
1. A global overview of the current state of deprescribing 2. Health policies and deprescribing: An introduction to health policies, knowledge translation, and the barriers, challenges, and enablers to health policy implementation 3. Deprescribing is an essential part of prescribing 4. Deprescribing in school curriculums: An overview of current education standards and what should be changed 5. The role of the multidisciplinary healthcare team in deprescribing 6. Looking to the future: Artificial intelligence in enhancing patient care 7. Challenges/barriers of deprescribing during Covid-19 8. Deprescribing in pallative care and Alzheimer's patients: Optimizing medication use for improved quality of life
"This publication serves as an overview of important concepts in medication use, such as polypharmacy and deprescribing...[And] provide[s] an assessment of current practices, limitations, and barriers to identify polypharmacy-related drug events for healthcare providers (HCPs) practicing in global healthcare settings...useful, but specific to the impact of polypharmacy on adverse drug events and challenges to implement deprescribing. The tools and strategies presented can be used to make meaningful changes to health care curriculum and health care policy."—©Doody’s Review Service, 2024, Susan Romann, PharmD, BCGP (Temple University School of Pharmacy)
- Edition: 1
- Latest edition
- Published: August 22, 2023
- Language: English
AE
Ali Elbeddini
Dr. Elbeddini is Affiliate Investigator in Epidemiology at Ottawa Hospital Research Institute (OHRI), Canada. He previously an Assistant Professor in Clinical Pharmacy at Skaggs School of Pharmacy, University of Colorado, USA and conducted post-doctorate research at Harvard Medical School (HMS) in Global Clinical Scholars Research Education program.
Affiliations and expertise
Assistant Professor, Family Medicine, Faculty of Medicine, University of Ottawa, CanadaRead Deprescribing and Polypharmacy in an Aging Population on ScienceDirect